Tumor necrosis factor beta A329G gene polymorphism and the association between patients with acute myocardial infarction

Volume: 38 Number: 3 September 1, 2013
Mehmet Canacankatan , Ahmet Sebe , Necmiye Canacankatan , Mehmet Oguzhan Ay , Meryem Genc Karanlık , Ufuk Saracoglu , Salim Satar , Salim Satar
EN TR

Tumor necrosis factor beta A329G gene polymorphism and the association between patients with acute myocardial infarction

Abstract

Aim: In this study, we aim to evaluate the efficacy of the tumor necrosis factor-beta A329G gene polymorphism in patients admitted to emergency department with chest pain complaint and diagnosed acute myocardial infarction. Material and Method: This study was planned as a prospective, randomized, controlled study and we started the study after the approval of Cukurova University Ethics Committee. Blood samples were taken from the patients who gave permission. Analysis of blood samples were studied in the Biochemistry Laboratory of Mersin University. DNA was extracted by High Pure PCR Template Preparation kit (High Pure PCR Template Preparation kit, Roche Diagnostic, Germany). TNF-β gene polymorphism A329G mutations were determined by using the Light Cycler instrument detection kit (Roche diagnostic, GmbH, Mannheim, Germany) in Light Cycler Real Time PCR. Statistical analysis of data was performed with SPSS 11.5 software package. The statistical significance level of p

Keywords

Gene polymorphism, cardiovascular diseases, myocardial infarction, tumor necrosis factor-beta, LDL, HDL.

References

  1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006; 367:1747-57.
  2. Türkiye’ de Sağlığa Bakış. TC Sağlık Bakanlığı. 2007; 47-50.
  3. Libby P. Changing concepts of atherogenesis J Intern Med. 2000; 247: 349-358.
  4. Kritchevsky SB, Cesari M, Pahor M. Inflammatory markers and cardiovascular health in older adults. Cardiovas Res. 2005; 66: 265–75.
  5. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999; 340: 115-26.
  6. Grundy SM. Atlas of aterosclerosis. Risk factors and treatment. 4th ed.1999. 1-30.
  7. Güner İ, Özmen D, Bayındır O. Sitokinler. T Klin J Med Sci. 1997; 17: 65-74.
  8. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991; 173: 209-19.
  9. Weinshenker BG, Hebrink D, Wingerchuk DM, Klein CJ, Atkinson E, O’Brien PC, et al. Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS. Neurology. 1999; 52: 1500-3.
  10. Grünenfelder J, Umbehr M, Plass A, Bestmann L, Maly FE, Zünd G, et al. Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor ß as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2004; 128: 92-97.
MLA
Canacankatan, Mehmet, et al. “Tümör Nekroz Faktör Beta A329G Gen Polimorfizmi Ve Akut Miyokard Infarktüsü Olan Hastalar Arasındaki Ilişki”. Cukurova Medical Journal, vol. 38, no. 3, Sept. 2013, pp. 365-73, https://izlik.org/JA58EF54TE.